Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2409)
All Articles published online
|
Mar 14, 2006 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schuierer MM, Graf E, Takemaru KI, Dietmaier W, Bosserhoff AK. Reduced expression of β-catenin inhibitor Chibby in colon carcinoma cell lines. World J Gastroenterol 2006; 12(10): 1529-1535 [PMID: 16570344 DOI: 10.3748/wjg.v12.i10.1529] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/1529.htm |
| Number | Citing Articles |
| 1 |
Katherine Karakoula, Blanca Suarez‐Merino, Samantha Ward, Kim P. Phipps, William Harkness, Richard Hayward, Dominic Thompson, Thomas S. Jacques, Brian Harding, John Beck, David G. T. Thomas, Tracy J. Warr. Real‐time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12‐q13. Genes, Chromosomes and Cancer 2008; 47(11): 1005 doi: 10.1002/gcc.20607
|
| 2 |
Alexandra Filipovich, Iris Gehrke, Simon J. Poll-Wolbeck, Karl-Anton Kreuzer. Physiological inhibitors of Wnt signaling. European Journal of Haematology 2011; 86(6): 453 doi: 10.1111/j.1600-0609.2011.01592.x
|
| 3 |
Gang Ren, De-an Zhao, Jue Xu, Bo-an Li. Expression of CBY and Methylation of CBY at Promoter Region in Human Laryngeal Squamous Cell Carcinoma. Tumori Journal 2015; 101(2): 215 doi: 10.5301/tj.5000242
|
| 4 |
Cheng‑Fu Cai, Li‑Man Liu, Han‑Jing Shangguan, Cun‑Shan Liu, Xian‑Yang Luo, Yi‑Meng Li. Anti-oncogenic activity of Chibby in the development of human nasopharyngeal carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.8009
|
| 5 |
HONG-TAO XU, QING-CHANG LI, SHUN-DONG DAI, XUE-MEI XIE, DI LIU, EN-HUA WANG. The expression patterns and correlations of chibby, β-catenin, and DNA methyltransferase-1 and their clinicopathological significance in lung cancers. APMIS 2011; 119(11): 750 doi: 10.1111/j.1600-0463.2011.02799.x
|
| 6 |
Victoria Fischer, Michael Wong, Feng-Qian Li, Ken-Ichi Takemaru. Chibby1 knockdown promotes mesenchymal-to-epithelial transition-like changes. Cell Cycle 2017; 16(5): 448 doi: 10.1080/15384101.2017.1281478
|
| 7 |
Ming‑Chang Yang, Shang‑Tao Chien, Tzu‑Feng Yang, Shih‑Yi Lin, Tai‑Min Lee, Yi‑Ren Hong. Downregulation of nuclear and cytoplasmic Chibby is associated with advanced cervical cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7050
|
| 8 |
Elisa Leo, Manuela Mancini, Michela Aluigi, Simona Luatti, Fausto Castagnetti, Nicoletta Testoni, Simona Soverini, Maria Alessandra Santucci, Giovanni Martinelli, Nanette H. Bishopric. BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia. PLoS ONE 2013; 8(12): e81425 doi: 10.1371/journal.pone.0081425
|
| 9 |
Manuela Mancini, Simona Soverini, Gabriele Gugliotta, Maria Alessandra Santucci, Gianantonio Rosti, Michele Cavo, Giovanni Martinelli, Fausto Castagnetti. Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia. Oncotarget 2017; 8(50): 88244 doi: 10.18632/oncotarget.21166
|
| 10 |
K. -I. Takemaru, M. Ohmitsu, F. -Q. Li. Protein-Protein Interactions as New Drug Targets. Handbook of Experimental Pharmacology 2008; 186: 261 doi: 10.1007/978-3-540-72843-6_11
|
| 11 |
Tatjana Seitz, Kim Freese, Peter Dietrich, Wolfgang Erwin Thasler, Anja Bosserhoff, Claus Hellerbrand. Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61510-4
|
| 12 |
Sulayman Mokhtarzada, Corey Yu, Anne Brickenden, Wing-Yiu Choy. Structural Characterization of Partially Disordered Human Chibby: Insights into Its Function in the Wnt-Signaling Pathway. Biochemistry 2011; 50(5): 715 doi: 10.1021/bi101236z
|
| 13 |
Cheng-fu Cai, Guo-dong Ye, Dong-yan Shen, Wei Zhang, Mao-li Chen, Xin-xin Chen, Da-xiong Han, Yan-jun Mi, Qi-cong Luo, Wang-yu Cai, Shu-yu Yang. Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0769-4
|
| 14 |
Karl Vandepoele, Katrien Staes, Vanessa Andries, Frans van Roy. Chibby interacts with NBPF1 and clusterin, two candidate tumor suppressors linked to neuroblastoma. Experimental Cell Research 2010; 316(7): 1225 doi: 10.1016/j.yexcr.2010.01.019
|
| 15 |
Siyang Wen, Yilu Qin, Rui Wang, Liping Yang, Huan Zeng, Pengpeng Zhu, Qiao Li, Yuxiang Qiu, Shanchun Chen, Yongcan Liu, Yixuan Hou, Xi Tang, Manran Liu, Gang Tu. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels. Cell Death & Disease 2021; 12(5) doi: 10.1038/s41419-021-03708-6
|
| 16 |
JUE XU, GANG REN, DE-AN ZHAO, BO-AN LI, CHENG-FU CAI, YI ZHOU, XIAN-YANG LUO. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells. Oncology Reports 2014; 32(5): 1947 doi: 10.3892/or.2014.3451
|
| 17 |
Feng‐Qian Li, Luis Chiriboga, Margaret A. Black, Ken‐Ichi Takemaru, Robert D. Raffaniello. Chibby is a weak regulator of β‐catenin activity in gastric epithelium. Journal of Cellular Physiology 2019; 234(2): 1871 doi: 10.1002/jcp.27062
|